Madden Advisory Services’s Pfizer PFE Stock Holding History

Madden Advisory Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-228	Closed	-$7K	–	190
2017 Q1	$7K	Buy	+228	New	+$7.19K	﹤0.01%	226
2015 Q4	–	Sell	-440	Closed	-$13K	–	217
2015 Q3	$13K	Hold	440	–	–	0.01%	201
2015 Q2	$13K	Buy	+440	New	+$14.3K	0.01%	209
2015 Q1	–	Sell	-270	Closed	-$8K	–	212
2014 Q4	$8K	Hold	270	–	–	﹤0.01%	244
2014 Q3	$8K	Hold	270	–	–	﹤0.01%	300
2014 Q2	$8K	Buy	270 +42	+18%	+$1.2K	﹤0.01%	288
2014 Q1	$7K	Buy	+228	New	+$6.8K	﹤0.01%	285
2013 Q4	–	Sell	-6	Closed	–	–	312
2013 Q3	$0	Hold	6	–	–	﹤0.01%	296
2013 Q2	$0	Buy	+6	New	+$166	﹤0.01%	307

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Madden Advisory Services's PFE Position: Q2 2017 in Review

Madden Advisory Services sold out of Pfizer (PFE) in Q2 2017, closing a stake of 228 shares — an estimated $7K sold.

Madden Advisory Services first reported a position in PFE in Q2 2013 and held it in 9 quarters. The position peaked at $13K in Q3 2015. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Madden Advisory Services reported no remaining Pfizer position as of Q2 2017 after selling out during the quarter.
Madden Advisory Services sold 228 Pfizer shares in Q2 2017, an estimated $7K.
Madden Advisory Services first reported a position in Pfizer in Q2 2013 and held it in 9 quarters.
Madden Advisory Services's Pfizer position peaked at $13K in Q3 2015.
2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Madden Advisory Services's 13F filing for Q2 2017, filed 11 Aug 2017.